Marvel Biosciences Corp. (TSXV: MRVL) Closes Second Tranche of Private Placement
Marvel Biosciences Corp. (TSXV: MRVL), along with its wholly owned subsidiary Marvel Biotechnology Inc., has closed the second tranche of its previously announced non-brokered private placement. This tranche involved the issuance of 150,000 units at a price of $0.125 per unit, resulting in gross …
Team Kalkine |
02 May 2025| Read Time : 10 Mins